NO975634D0 - Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater - Google Patents
Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparaterInfo
- Publication number
- NO975634D0 NO975634D0 NO975634A NO975634A NO975634D0 NO 975634 D0 NO975634 D0 NO 975634D0 NO 975634 A NO975634 A NO 975634A NO 975634 A NO975634 A NO 975634A NO 975634 D0 NO975634 D0 NO 975634D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- tiludronate
- hydrates
- preparation
- stable
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229940019375 tiludronate Drugs 0.000 title 1
- -1 tiludronate hydrates Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3865—Polyphosphonic acids containing sulfur substituents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/488,986 US5656288A (en) | 1995-06-08 | 1995-06-08 | Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| PCT/US1996/008790 WO1996041618A1 (en) | 1995-06-08 | 1996-06-04 | Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975634D0 true NO975634D0 (no) | 1997-12-04 |
| NO975634L NO975634L (no) | 1998-01-29 |
Family
ID=23941935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975634A NO975634L (no) | 1995-06-08 | 1997-12-04 | Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5656288A (no) |
| EP (1) | EP0831789A1 (no) |
| JP (1) | JPH11507924A (no) |
| AR (1) | AR003434A1 (no) |
| AU (1) | AU5980896A (no) |
| BR (1) | BR9609477A (no) |
| CA (1) | CA2223568A1 (no) |
| MX (1) | MX9709838A (no) |
| NO (1) | NO975634L (no) |
| WO (1) | WO1996041618A1 (no) |
| ZA (1) | ZA964752B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1378234A1 (en) * | 1996-05-17 | 2004-01-07 | MERCK & CO. INC. | Effervescent bisphosphonate formulation |
| US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
| JP2000511178A (ja) * | 1996-05-17 | 2000-08-29 | メルク エンド カンパニー インコーポレーテッド | 発泡性ビスホスホネート製剤 |
| EP0998932A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| EP0998933A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
| US6410520B2 (en) * | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| US7488496B2 (en) | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
| US6987111B2 (en) * | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
| US7164023B2 (en) * | 2003-09-04 | 2007-01-16 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| NZ545804A (en) * | 2003-09-19 | 2009-09-25 | Wisconsin Alumni Res Found | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694558B1 (fr) * | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant. |
-
1995
- 1995-06-08 US US08/488,986 patent/US5656288A/en not_active Expired - Fee Related
-
1996
- 1996-06-04 AU AU59808/96A patent/AU5980896A/en not_active Abandoned
- 1996-06-04 BR BR9609477A patent/BR9609477A/pt not_active Application Discontinuation
- 1996-06-04 CA CA002223568A patent/CA2223568A1/en not_active Abandoned
- 1996-06-04 WO PCT/US1996/008790 patent/WO1996041618A1/en not_active Application Discontinuation
- 1996-06-04 EP EP96917140A patent/EP0831789A1/en not_active Withdrawn
- 1996-06-04 JP JP9503130A patent/JPH11507924A/ja not_active Withdrawn
- 1996-06-06 ZA ZA964752A patent/ZA964752B/xx unknown
- 1996-06-11 AR ARP960103106A patent/AR003434A1/es unknown
-
1997
- 1997-12-04 NO NO975634A patent/NO975634L/no unknown
- 1997-12-08 MX MX9709838A patent/MX9709838A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2223568A1 (en) | 1996-12-27 |
| AU5980896A (en) | 1997-01-09 |
| ZA964752B (en) | 1997-01-13 |
| JPH11507924A (ja) | 1999-07-13 |
| NO975634L (no) | 1998-01-29 |
| MX9709838A (es) | 1998-08-30 |
| EP0831789A1 (en) | 1998-04-01 |
| US5656288A (en) | 1997-08-12 |
| AR003434A1 (es) | 1998-08-05 |
| BR9609477A (pt) | 1999-05-25 |
| WO1996041618A1 (en) | 1996-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002835L (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
| NO944164D0 (no) | Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent | |
| EP0863762A4 (en) | PROCESS FOR THE PRODUCTION AND USE OF LIQUID PLASMA PROTEIN PREPARATIONS | |
| DK42093D0 (da) | Administrationsmetode | |
| EE03280B1 (et) | Pidurdatud vabanemisega ravimkuulikesed ja neid sisaldav ravimpreparaat | |
| FI973278A (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| DK0839153T3 (da) | Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider | |
| KR970000228A (ko) | S-에토돌락의 경구용 제제 | |
| DK0702344T3 (da) | Etiketkontinuum og fremgangsmåde til fremstilling deraf | |
| NO972477D0 (no) | Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse | |
| DK0635004T3 (da) | 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf | |
| NO975634D0 (no) | Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater | |
| DK0805797T3 (da) | Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer | |
| NO993807L (no) | Fremgangsmaate og apparatur for fremstilling av hydrolysater av krill | |
| DK0735042T3 (da) | Maltitolsammensætning og fremgangsmåde til fremstilling deraf | |
| IL117397A (en) | Substituted naphthyl compounds and pharmaceutical compositions comprising them | |
| NO961252D0 (no) | Fremgangsmåte for fremstilling av N-metyl-3-(1-metyl-4-piperidinyl)-14-indol-5-etansulfonamid | |
| NO990520L (no) | FremgangsmÕte for fremstilling av cykliske depsipeptidforbindelser og et nytt cyklisk depsipeptid | |
| NO932860D0 (no) | Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat | |
| DK0565105T3 (da) | Forgrenede cyclodextriner og fremgangsmåder til fremstilling heraf | |
| NO932912D0 (no) | Preparat og fremgangsmaater til generering av ben | |
| NO179244C (no) | Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal | |
| ZA961050B (en) | Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them | |
| NO952261D0 (no) | Antacidiumforbindelser og fremgangsmåte for fremstilling derav | |
| NO942531D0 (no) | Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener |